Novus Diagnostics
Novus Diagnostics is dedicated to empowering clinicians with rapid diagnostic solutions for infectious diseases, focusing on sepsis. Using patented microfluidic electrochemical sensors and advanced algorithms, their platform delivers results in 15 minutes, enabling targeted treatment at the bedside. The company has received multiple awards and recognitions for its innovative technology and research impact.
Industries
Nr. of Employees
small (1-50)
Novus Diagnostics
Products
Rapid bedside diagnostic test for bloodstream infections
Point-of-care diagnostic test that combines microfluidic electrochemical sensors with diagnostic algorithms to detect bloodstream infection and classify the causative pathogen type (gram-negative, gram-positive, fungal) with results in approximately 15 minutes.
Rapid bedside diagnostic test for bloodstream infections
Point-of-care diagnostic test that combines microfluidic electrochemical sensors with diagnostic algorithms to detect bloodstream infection and classify the causative pathogen type (gram-negative, gram-positive, fungal) with results in approximately 15 minutes.
Services
Clinical pilot partnerships and demonstrations
Collaborative on-site demonstrations and pilot engagements with healthcare institutions to assess workflow integration, usability and clinical applicability.
Clinical pilot partnerships and demonstrations
Collaborative on-site demonstrations and pilot engagements with healthcare institutions to assess workflow integration, usability and clinical applicability.
Expertise Areas
- Rapid point-of-care infectious disease diagnostics
- Sepsis diagnostics and triage support
- Microfluidic sensor development
- Electrochemical sensing
Key Technologies
- Microfluidics
- Electrochemical sensors
- Point-of-care/bedside diagnostics
- Advanced diagnostic algorithms